Simplify Asset Management Inc. Sells 19,885 Shares of Establishment Labs Holdings Inc. $ESTA

Simplify Asset Management Inc. decreased its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 27.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,009 shares of the company’s stock after selling 19,885 shares during the period. Simplify Asset Management Inc. owned 0.18% of Establishment Labs worth $3,010,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. Quarry LP acquired a new position in Establishment Labs in the third quarter valued at approximately $34,000. Kestra Advisory Services LLC acquired a new stake in shares of Establishment Labs during the 4th quarter worth approximately $47,000. Osaic Holdings Inc. grew its position in shares of Establishment Labs by 900.0% during the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock worth $85,000 after buying an additional 1,800 shares during the period. MV Capital Management Inc. bought a new stake in shares of Establishment Labs in the 4th quarter valued at $146,000. Finally, Truist Financial Corp bought a new stake in shares of Establishment Labs in the 4th quarter valued at $200,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. TD Cowen reissued a “buy” rating on shares of Establishment Labs in a research note on Monday, June 8th. Wall Street Zen downgraded shares of Establishment Labs from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. BTIG Research upped their price objective on shares of Establishment Labs from $88.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Citigroup restated a “neutral” rating on shares of Establishment Labs in a research note on Wednesday, May 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a research report on Wednesday, June 24th. Seven equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Establishment Labs has an average rating of “Moderate Buy” and an average price target of $87.14.

Establishment Labs Price Performance

Shares of NASDAQ ESTA opened at $89.25 on Friday. The stock has a market capitalization of $2.63 billion, a P/E ratio of -59.90 and a beta of 1.06. The company has a 50-day moving average price of $75.84 and a 200-day moving average price of $70.92. Establishment Labs Holdings Inc. has a 1 year low of $33.35 and a 1 year high of $90.50. The company has a debt-to-equity ratio of 16.82, a current ratio of 2.96 and a quick ratio of 1.91.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Thursday, May 7th. The company reported ($0.45) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). The business had revenue of $59.88 million during the quarter, compared to analyst estimates of $57.40 million. Establishment Labs had a negative return on equity of 218.77% and a negative net margin of 19.05%.The company’s revenue was up 44.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.70) EPS. On average, equities research analysts forecast that Establishment Labs Holdings Inc. will post -1.07 EPS for the current fiscal year.

Insider Activity at Establishment Labs

In other news, Director Quiros Juan Jose Chacon sold 105,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total value of $7,919,100.00. Following the transaction, the director owned 927,504 shares in the company, valued at $69,952,351.68. This trade represents a 10.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 292,500 shares of company stock valued at $20,591,021 over the last three months. Corporate insiders own 9.99% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.